Replies to post #265773 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

I was wondering if there is a way to get numbers about the SAS applications and how the company will price 2-73 under SAS.

I think you under estimate the effect of a successful Rett trial.

True that there are not a huge number of potential patients. There are other considerations, such as validating the MOA and being the first placebo controlled trial. Then there is the potential to influence the TGA towards a PA. Of course there is FDA incentive program if 2-73 gets approved in the US for Rett.

[rocalinda]

I believe any revenue is highly relevant. It validates the commercial value of the company. Obviously the biggest impact of Rett’s success would be the fact that the drug works and gives PDD and Alzheimer’s a higher probability.

Just my humble opinion.